|
Report Date : |
12.06.2013 |
IDENTIFICATION DETAILS
|
Name : |
TABUK PHARMACEUTICAL RESEARCH CO LTD |
|
|
|
|
Registered Office : |
Al Zahran Plaza,
7th Circle, P O Box 142904, Amman 11844 |
|
|
|
|
Country : |
Jordan |
|
|
|
|
Date of Incorporation : |
04.03.2007 |
|
|
|
|
Com. Reg. No.: |
13846 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Providers of pharmaceutical research and development services |
|
|
|
|
No. of Employees : |
45 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Jordan |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
jordan ECONOMIC OVERVIEW
Jordan's economy is among the smallest in the Middle East, with
insufficient supplies of water, oil, and other natural resources, underlying
the government's heavy reliance on foreign assistance. Other economic
challenges for the government include chronic high rates of poverty,
unemployment, inflation, and a large budget deficit. Since assuming the throne
in 1999, King ABDALLAH has implemented significant economic reforms, such as
opening the trade regime, privatizing state-owned companies, and eliminating
some fuel subsidies, which in the last decade spurred economic growth by
attracting foreign investment and creating some jobs. The global economic
slowdown and regional turmoil, however, have depressed Jordan's GDP growth,
impacting export-oriented sectors, construction, and tourism. In 2011 and 2012,
the government approved two economic relief packages and a budgetary
supplement, meant to improve the living conditions for the middle and poor
classes. Jordan's finances have also been strained by a series of natural gas
pipeline attacks in Egypt, causing Jordan to substitute more expensive diesel
imports, primarily from Saudi Arabia, to generate electricity. Jordan is
currently exploring nuclear power generation in addition to the exploitation of
abundant oil shale reserves and renewable technologies to forestall energy
shortfalls. In 2012, to correct budgetary and balance of payments imbalances,
Jordan entered into a $2.1 billion, multiple year International Monetary Fund
Stand-By Arrangement. Jordan's financial sector has been relatively isolated
from the international financial crisis because of its limited exposure to
overseas capital markets. Jordan will continue to depend heavily on foreign
assistance to finance the deficit in 2013.
|
Source : CIA |
Company Name : TABUK PHARMACEUTICAL RESEARCH CO LTD
Country of Origin : Jordan
Legal Form : Limited Liability Company
Registration Date : 4th March 2007
Commercial Registration Number : 13846
Chamber Membership Number : 134308
National ID Number : 200021274
Issued Capital : JD 500,000
Paid up Capital : JD 500,000
Total Workforce : 45
Activities : Providers of pharmaceutical research and development services
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
Person Interviewed : Dr Sami Mostafa Qassem, Managing Director
TABUK PHARMACEUTICAL RESEARCH CO LTD
Registered &
Physical Address
Location : Al Zahran Plaza, 7th
Circle
PO Box : 142904
Town : Amman 11844
Country : Jordan
Telephone : (962-6) 5822188 / 5851516
Facsimile : (962-6) 5817758
Mobile : (962-77) 7749336
Email : sami@tpmc-jo.com / mai.omran@tpmc-jo.com
Premises
Subject operates
from a medium sized suite of offices that are rented and located in the Central
Business Area of Amman.
Name Position
·
Dr Sami
Mostafa Qassem Managing
Director
·
Dr
Mohamed Saifi Research
and Development Manager
·
Mai
Omran Purchase
Officer
·
Mohamed
Humran Accounts
Supervisor
Date of Establishment : 4th
March 2007
Legal Form :
Limited Liability Company
Commercial Reg. No. : 13846
Chamber Member No. : 134308
National ID No. :
200021274
Issued Capital : JD 500,000
Paid up Capital : JD 500,000
Name of Shareholder
(s) Percentage
·
Tabuk
Pharmaceutical Manufacturing Co 100%
Amman
Tel: (962-6) 5534441
Activities: Engaged in the provision of pharmaceutical
research and development services.
Subject has a workforce
of 45 employees.
Companies
registered in Jordan are not legally required to make their accounts public and
no financial information was released by the company or submitted by outside
sources.
·
Jordan
Kuwait Bank
Abdali Branch
PO Box: 9776
Amman
Tel: (962-6) 5688814
No complaints
regarding subject’s payments have been reported.
According to local
sources, subject enjoys a good reputation for the quality of its products with nothing
detrimental uncovered regarding the manner in which operations are conducted.
As such the company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.58.93 |
|
UK Pound |
1 |
Rs.91.81 |
|
Euro |
1 |
Rs.78.18 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.